These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 19954275)

  • 1. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine XR: current status for the treatment of major depressive disorder.
    Pae CU; Sohi MS; Seo HJ; Serretti A; Patkar AA; Steffens DC; Masand PS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1165-73. PubMed ID: 20307622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder.
    Bauer M; El-Khalili N; Datto C; Szamosi J; Eriksson H
    J Affect Disord; 2010 Dec; 127(1-3):19-30. PubMed ID: 20884063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies.
    Weisler RH; Montgomery SA; Earley WR; Szamosi J; Lazarus A
    Int Clin Psychopharmacol; 2012 Jan; 27(1):27-39. PubMed ID: 22027845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.
    Bortnick B; El-Khalili N; Banov M; Adson D; Datto C; Raines S; Earley W; Eriksson H
    J Affect Disord; 2011 Jan; 128(1-2):83-94. PubMed ID: 20691481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarate.
    Sheehan DV; Locklear J; Svedsäter H; Datto C
    Int Clin Psychopharmacol; 2012 Sep; 27(5):239-48. PubMed ID: 22859063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended release quetiapine fumarate in patients with major depressive disorder: suicidality data from acute and maintenance studies.
    Weisler R; Montgomery SA; Earley WR; Szamosi J; Eriksson H
    J Clin Psychiatry; 2014 May; 75(5):520-7. PubMed ID: 24816198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE
    Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of extended-release quetiapine fumarate monotherapy in the treatment of patients with major depressive disorder.
    Weisler R; McIntyre RS
    Expert Rev Neurother; 2013 Nov; 13(11):1161-82. PubMed ID: 24175720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study.
    El-Khalili N; Joyce M; Atkinson S; Buynak RJ; Datto C; Lindgren P; Eriksson H
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):917-32. PubMed ID: 20175941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of quetiapine extended release in the treatment of bipolar depression.
    Cristancho MA; Thase ME
    Adv Ther; 2010 Nov; 27(11):774-84. PubMed ID: 20835785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extended-release formulation of quetiapine fumarate (quetiapine XR) adjunctive treatment in partially responsive generalized anxiety disorder (GAD): An open label naturalistic study.
    Gabriel A
    Clin Ter; 2011; 162(2):113-8. PubMed ID: 21533316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine: a review of its use in the management of bipolar depression.
    Sanford M; Keating GM
    CNS Drugs; 2012 May; 26(5):435-60. PubMed ID: 22519923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pooled analysis of sustained response rates for extended release quetiapine fumarate as monotherapy or adjunct to antidepressant therapy in patients with major depressive disorder.
    Vieta E; Bauer M; Montgomery S; McIntyre RS; Szamosi J; Earley WR; Eriksson H
    J Affect Disord; 2013 Sep; 150(2):639-43. PubMed ID: 23497790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual functioning in patients with major depressive disorder in randomized placebo-controlled studies of extended release quetiapine fumarate.
    Clayton AH; Locklear JC; Svedsäter H; McIntyre RS
    CNS Spectr; 2014 Apr; 19(2):182-96. PubMed ID: 24067192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy.
    Weisler R; McIntyre RS; Bauer M
    Expert Rev Neurother; 2013 Nov; 13(11):1183-200. PubMed ID: 24175721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.